复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R512.6+2

基金项目:


Clinical Study on Compound Biejia Ruangan Tablets for Liver Fibrosis Induced by Chronic Hepatitis B
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化的临床疗效。方法:选取112 例慢性乙型肝炎肝纤维化患者,按随机数字表法分为治疗组和对照组各56 例。对照组给予富马酸替诺福韦二吡呋酯片治疗;治疗组在对照组的基础上加用复方鳖甲软肝片治疗。2 组连续治疗12 个月。观察比较2 组肝功能指标[天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、总胆红素(TBil)、γ-谷氨酸酰基转移酶(GGT)]、肝纤维化指标[透明质酸(HA)、Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(Ⅳ-C)、层黏蛋白(LN)]水平变化及临床疗效。结果:治疗组总有效率为92.86%,显著高于对照组的76.79%,组间比较,差异有统计学意义(P<0.05)。治疗前,2 组血清AST、ALT、GGT、TBil 水平比较,差异无统计学意义(P>0.05);治疗后,2 组AST、ALT、GGT、TBil 水平均较治疗前明显降低(P<0.05),且治疗组上述各项肝功能指标均低于对照组(P<0.05)。治疗前,2 组血清HA、PCⅢ、Ⅳ-C、LN 水平比较,差异无统计学意义(P>0.05);治疗后,2 组HA、PCⅢ、Ⅳ-C、LN 水平均较治疗前明显降低(P<0.05),且治疗组上述各项肝纤维化指标均低于对照组(P<0.05)。结论:在西医常规治疗的基础上,加用复方鳖甲软肝片治疗慢性乙型肝炎纤维化疗效显著,能更好地改善患者肝功能及肝纤维化指标。

    Abstract:

    Abstract: Objective: To observe the clinical effect of compound Biejia Ruangan Tablets for patients with liver fibrosis induced by chronic hepatitis B. Methods:A total of 112 cases of patients with liver fibrosis induced by chronic hepatitis B were divided into the treatment group and the control group according to the random number table method,with 56 cases in each group. The control group was treated with Tenofovir Disoproxil Fumarate Tablets, and the treatment group was additionally treated with compound Biejia Ruangan Tablets based on the treatment of the control group. Both groups were treated for 12 months. The changes in levels of liver function indexes including aspartate aminotransferase(AST), alanine aminotransferase(ALT), total bilirubin(TBil) and γ- glutamate acyltransferase(GGT), and liver fibrosis indexes including hyaluronic acid(HA),type Ⅲ procollagen(PCⅢ),type Ⅳ collagen(Ⅳ-C) and laminin(LN), as well as clinical effects in the two groups were compared. Results:The total effective rate was 92.86% in the treatment group, significantly higher than that of 76.79% in the control group, the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of AST,ALT,GGT and TBil in serum between the two groups(P>0.05). After treatment,the levels of AST, ALT, GGT and TBil in the two groups were significantly decreased when compared with those before treatment(P<0.05), and the above indexes in the treatment group were significantly lower than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of HA,PCⅢ,Ⅳ- C and LN in serum between the two groups(P>0.05). After treatment, the levels of HA, PC Ⅲ, Ⅳ- C and LN in the two groups were significantly decreased when compared with those before treatment(P<0.05),and the above liver fibrosis indexes in the treatment group were significantly lower than those in the control group(P<0.05). Conclusion: Based on routine western medicine treatment,the additional application of compound Biejia Ruangan Tablets for liver fibrosis induced by chronic hepatitis B has a significant curative effect, which can better improve the indexes of liver function and liver fibrosis of patients.

    参考文献
    相似文献
    引证文献
引用本文

丁小平,邱彬,施海斌.复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化临床研究[J].新中医,2022,54(22):72-75

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-27
  • 出版日期: